Bioneutral Group Inc (BONU) financial statements (2020 and earlier)

Company profile

Business Address 211 WARREN STREET
NEWARK, NJ 07103
State of Incorp. NV
Fiscal Year End October 31
SIC 281 - Industrial Inorganic Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

7/31/2014
TTM
10/31/2013
10/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 00
Cash and cash equivalents 00
Receivables 00
Inventory, net of allowances, customer advances and progress billings 00
Inventory 00
Total current assets: 00
Noncurrent Assets
Property, plant and equipment 00
Intangible assets, net (including goodwill) 910
Intangible assets, net (excluding goodwill) 910
Other noncurrent assets 0
Prepaid expense and other noncurrent assets0
Total noncurrent assets: 910
TOTAL ASSETS: 910
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 11
Other undisclosed accounts payable and accrued liabilities 11
Debt 0 
Deferred compensation liability 10
Derivative instruments and hedges, liabilities 0 
Due to related parties 00
Other undisclosed current liabilities 00
Total current liabilities: 32
Noncurrent Liabilities
Other undisclosed noncurrent liabilities 11
Total noncurrent liabilities: 11
Total liabilities: 42
Temporary equity, carrying amount 00
Stockholders' equity
Stockholders' equity attributable to parent, including: 57
Common stock 00
Additional paid in capital 6364
Accumulated deficit (58)(55)
Other undisclosed stockholders' equity attributable to parent (0)(2)
Stockholders' equity attributable to noncontrolling interest (0)0
Total stockholders' equity: 58
Other undisclosed liabilities and equity (0)(0)
TOTAL LIABILITIES AND EQUITY: 910

Income statement (P&L) ($ in millions)

7/31/2014
TTM
10/31/2013
10/31/2012
Revenues 00
Cost of revenue (0)(0)
Gross profit: 00
Operating expenses (3)(3)
Operating loss: (3)(3)
Nonoperating expense (0) 
Investment income, nonoperating 0 
Interest and debt expense (0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes 00
Loss from continuing operations before income taxes: (3)(3)
Income tax expense  (2)
Loss before gain (loss) on sale of properties: (3)(5)
Other undisclosed net income  2
Net loss: (3)(3)
Net income attributable to noncontrolling interest 00
Net loss available to common stockholders, diluted: (3)(2)

Comprehensive Income ($ in millions)

7/31/2014
TTM
10/31/2013
10/31/2012
Net loss: (3)(3)
Comprehensive loss: (3)(3)
Comprehensive loss, net of tax, attributable to noncontrolling interest (0)(0)
Comprehensive loss, net of tax, attributable to parent: (3)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: